Contineum Therapeutics, Inc.
CTNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855175
In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Contineum Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 52 | +4 |
| Shares | 13.0M | 396.3K | 13.7M | +1.09M (+8.7%) |
| Value | $229.2M | $6.98M | $258.4M | +$36.2M (+16.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Contineum Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 404,772 | $7.75M | 0.00% |
| Winton Group Ltd | 11,136 | $213.1K | 0.01% |
| HRT Financial LP | 11,142 | $213.0K | 0.00% |
| ADAR1 Capital Management, LLC | 8,967 | $171.6K | 0.03% |
| Mirae Asset Global ETFs Holdings Ltd. | 3,077 | $58.9K | 0.00% |
| Harbor Capital Advisors, Inc. | 168 | $3.00K | 0.00% |
| CWM, LLC | 28 | $1.00K | 0.00% |
| Nisa Investment Advisors, LLC | 29 | $555 | 0.00% |
| Sterling Capital Management LLC | 13 | $249 | 0.00% |
Sold out (5)
Institutions that held Contineum Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Citadel Advisors LLC | 127,785 | $2.25M |
| Walleye Capital LLC | 44,185 | $778.1K |
| Invesco Ltd. | 10,771 | $189.7K |
| Sandia Investment Management LP | 5,000 | $88.0K |
| MetLife Investment Management | 1,926 | $33.9K |
Not filed for Q3 2024 yet (1)
Institutions that held Contineum Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 396,273 | $6.98M |